CA Patent

CA2619605A1 — Inhalation therapy device comprising an ampoule for storing a medicament to be nebulised

Assigned to PARI Pharma GmbH · Expires 2007-02-22 · 19y expired

What this patent protects

The invention relates to an inhalation therapy device (1) which comprises an atomizer (2) for atomizing a drug which is advantageously present in the form of a fluid (8) into an atomization chamber (12) so that an aerosol or mist (21) is provided in the atomization chamber (12). …

USPTO Abstract

The invention relates to an inhalation therapy device (1) which comprises an atomizer (2) for atomizing a drug which is advantageously present in the form of a fluid (8) into an atomization chamber (12) so that an aerosol or mist (21) is provided in the atomization chamber (12). The patient or user can inhale the aerosol (21) produced by the atomizer (2) from the atomization chamber (12) via a mouthpiece (13). The ampoule (100) is inserted into an ampoule holder (3) holding the fluid-containing ampoule (100). The inhalation therapy device (1) also comprises an opening unit (4) for opening the fluid-containing ampoule (100). The ampoule holder (3) advantageously comprises a first part (31), disposed displaceably in relation to the opening unit (4), thereby allowing an ampoule (100) present in the ampoule holder to be displaced in the direction of the opening unit.

Drugs covered by this patent

Patent Metadata

Patent number
CA2619605A1
Jurisdiction
CA
Classification
Expires
2007-02-22
Drug substance claim
No
Drug product claim
No
Assignee
PARI Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.